PACS Group, Inc.
PACS Healthcare Medical Care Facilities
PACS Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 29.3% from fiscal 2024.
- Revenue
- +11.5%
- EPS
- +16.4%
- Free cash flow
- −4.31%
- Total debt
- +7.48%
Quarter to September 2026, against a year earlier
Follow PACS
Alert me
PACS Group, Inc. (PACS) Current ratio
PACS Group, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 0.8×, down 0.3× from fiscal 2025 (1.1×). That is below the Medical Care Facilities industry median of 1.4× and below the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 1.1× | 11.40% |
| FY2024 | 1.0× | (39.33%) |
| FY2023 | 1.6× | 49.60% |
| FY2022 | 1.1× | — |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 0.8× | (12.20%) |
| Jun 2026 | 0.9× | (8.33%) |
| Mar 2026 | 1.0× | (6.85%) |
| Dec 2025 | 1.1× | 13.54% |
| 9 more quarters | Free account |
Current ratio against peers
| Company | Current ratio |
|---|---|
| OPCH Option Care Health, Inc. compare | 1.5× |
| LFST LifeStance Health Group, Inc. compare | 1.4× |
| DVA DaVita Inc. compare | 1.4× |
| UHS Universal Health Services, Inc. compare | 1.4× |
| CON Concentra Group Holdings Parent, Inc. compare | 1.3× |
| ENSG The Ensign Group, Inc. compare | 1.2× |
| CHE Chemed Corporation compare | 1.1× |
| FMS Fresenius Medical Care AG & Co. KGaA compare | 1.0× |
| PACS PACS Group, Inc. | 0.8× |
| Medical Care Facilities industry median | 1.4× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on PACS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Beneish M-score
- The full statement